Resources about the medication Duloxetine (Cymbalta).
Cymbalta (duloxetine) has been approved by the FDA. Cymbalta targets two chemical messengers in the body, serotonin and norepinephrine. According to a report in the journal Arthritis & Rheumatism, Cymbalta seems to be effective in treating the symptoms associated with fibromyalgia in women, but not in men.
Overview, side effects, interactions and usage information for Cymbalta. From About.com Drug Finder.
A profile of the antidepressant drug Duloxetine (Cymbalta).
Official Cymbalta information site provided by Lilly.
Duloxetine has no clinically meaningful effects on body weight in most patients, researchers reported at the 1992 annual meeting of the American Psychiatric Association (APA).
One of the chief complaints with most antidepressants is it takes so long to feel relief--if you are going to experience relief at all. You may well go on a several weeks trial of a drug only to find that it doesn't work for you. A new drug, Cymbalta, often gives relief very quickly, which is good news for those experiencing debilitating depression.
Many people who have dual issues with pain and depression are finding Cymbalta helps them. This article discusses Cymbalta's approval for diabetic neuropathic pain.
I've included this site because it pulls together several articles about Cymbalta and appears to be periodically updated.
When a patient begins treatment or alters their dose it is wise for them to be monitored for any increased signs of suicidality, agitation, irritability, etc. This is especially true for children and teens. This story is about Traci Johnson, a young woman who reportedly did not have depression, who hanged herself while participating in Lilly's clinical trials for Cymbalta.
